Literature DB >> 20005421

The development of intermediate care services in England.

John Young1.   

Abstract

The origins of intermediate care as a health policy in England are reviewed. The randomized controlled trial (RCT) evidence for the various intermediate care service models is discussed from the perspectives of clinical, service and economic outcomes. This evidence base suggests that the hospital-at-home approach is currently the best RCT supported intermediate care service model. It is argued that intermediate care in England has yet to fulfil its expectations. Changing staff skills and attitudes has proved a challenge, and the integration of intermediate care with mainstream services has been especially difficult. New national guidance has been produced that is attempting to refocus intermediate care its intended target group of frail older people, and not to specifically exclude older people with mental health problems.

Entities:  

Mesh:

Year:  2009        PMID: 20005421     DOI: 10.1016/S0167-4943(09)70008-1

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  19 in total

1.  Advancing Innovation in Skilled Nursing Facilities through Academic Collaborations.

Authors:  Allison M Gustavson; Rebecca S Boxer; Amy Nordon-Craft; Robin L Marcus; Andrea Daddato; Jennifer E Stevens-Lapsley
Journal:  Phys Ther J Policy Adm Leadersh       Date:  2018-08

Review 2.  Intermediate care: the role of medicines management.

Authors:  Anna N Millar; Carmel M Hughes; A Peter Passmore; Cristín Ryan
Journal:  Drugs Aging       Date:  2014-01       Impact factor: 3.923

3.  Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards.

Authors:  Marit Stordal Bakken; Anette Hylen Ranhoff; Anders Engeland; Sabine Ruths
Journal:  Scand J Prim Health Care       Date:  2012-07-25       Impact factor: 2.581

4.  Is Comprehensive Geriatric Assessment Admission Avoidance Hospital at Home an Alternative to Hospital Admission for Older Persons? : A Randomized Trial.

Authors:  Sasha Shepperd; Chris Butler; Andrea Cradduck-Bamford; Graham Ellis; Alastair Gray; Anthony Hemsley; Pradeep Khanna; Peter Langhorne; Sam Mort; Scott Ramsay; Rebekah Schiff; David J Stott; Angela Wilkinson; Ly-Mee Yu; John Young
Journal:  Ann Intern Med       Date:  2021-04-20       Impact factor: 25.391

5.  The choice of alternatives to acute hospitalization: a descriptive study from Hallingdal, Norway.

Authors:  Oystein Lappegard; Per Hjortdahl
Journal:  BMC Fam Pract       Date:  2013-06-22       Impact factor: 2.497

6.  The influence of an intermediate care hospital on health care utilization among elderly patients--a retrospective comparative cohort study.

Authors:  Unni Dahl; Roar Johnsen; Rune Sætre; Aslak Steinsbekk
Journal:  BMC Health Serv Res       Date:  2015-02-01       Impact factor: 2.655

7.  Effectiveness of an intermediate care hospital on readmissions, mortality, activities of daily living and use of health care services among hospitalized adults aged 60 years and older--a controlled observational study.

Authors:  Unni Dahl; Aslak Steinsbekk; Roar Johnsen
Journal:  BMC Health Serv Res       Date:  2015-08-28       Impact factor: 2.655

8.  The Contribution of Case Mix, Skill Mix and Care Processes to the Outcomes of Community Hospitals: A Population-Based Observational Study.

Authors:  Davide Pianori; Kadjo Yves Cedric Adja; Jacopo Lenzi; Giulia Pieri; Andrea Rossi; Chiara Reno; Maria Pia Fantini
Journal:  Int J Integr Care       Date:  2021-06-21       Impact factor: 5.120

9.  The role of an intermediate unit in a clinical pathway.

Authors:  Anne-Kari Johannessen; Hilde Lurås; Sissel Steihaug
Journal:  Int J Integr Care       Date:  2013-03-26       Impact factor: 5.120

10.  Reducing hospital bed use by frail older people: results from a systematic review of the literature.

Authors:  Ian Philp; Karen A Mills; Bhomraj Thanvi; Kris Ghosh; Judith F Long
Journal:  Int J Integr Care       Date:  2013-12-05       Impact factor: 5.120

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.